GlassScriptPhysician profile
Sara A Stanton
NPI 1720273527
$9,500.47
in general payments reported to CMS, 2019-2025
48 companies · $1,224 in 2025
The $1,224 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,267 · 2022: $2,190 · 2023: $1,918 · 2024: $1,901 · 2025: $1,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,929 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,928.71 |
| Education | $114.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,125.49 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $861.38 | 2021-2025 | |
| Novo Nordisk INC | $811.76 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $744.21 | 2021-2024 | Mounjaro, Zepbound, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $736.63 | 2021-2025 | Jardiance, Tradjenta, Stiolto Respimat |
| Otsuka America Pharmaceutical, INC. | $551.21 | 2022-2025 | Rexulti, Nuedexta |
| Amgen INC. | $428.06 | 2021-2025 | Evenity |
| Endo Pharmaceuticals INC. | $321.99 | 2021-2024 | Xiaflex |
| Janssen Pharmaceuticals, INC | $268.52 | 2021-2022 | |
| Astellas Pharma US INC | $244.24 | 2021-2025 | Veozah |
| Teva Pharmaceuticals USA, INC. | $242.07 | 2021-2024 | Austedo Xr, Austedo |
| Radius Health, INC. | $237.54 | 2021-2025 | Tymlos |
| Pfizer INC. | $233.92 | 2023-2024 | |
| Dexcom, INC. | $227.09 | 2021-2024 | Dexcom G6 Transmitter |
| Lundbeck LLC | $206.34 | 2023-2025 | Rexulti, Vyepti |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.